Specialty
Novartis has a diverse portfolio of medications to treat disorders that affect the body’s immune response and occur when the immune system is overactive and/or begins to fight against itself. In Integrated Hospital Care, our focus is on the following disease areas:
Transplantation
We have a broad portfolio of immunosuppressants. These include Neoral (cyclosporine), Simulect (basiliximab), myfortic (micophenolic acid) and Certican/Zortress (everolimus).
Nephrology / Hepatitis
Our portfolio includes Tyzeka/Sebivo (telbivudine).
Autoinflammatory and autoimmune diseases
An important product in this disease area is Ilaris (canakinumab).
